Saturday, July 11, 2026

Drug profile · INN

cyproterone

cyproterone (CYPROTERONE SANDOZ) is an FDA-listed pharmaceutical active ingredient. Associated with Amdipharm Mercury (Australia) Pty Limited.

TGA: approved
Patents linked 2
Pipeline programs 3
News articles 0
Drug details — cyproterone

Quick answer

cyproterone (CYPROTERONE SANDOZ) is an FDA-listed pharmaceutical active ingredient. Associated with Amdipharm Mercury (Australia) Pty Limited.

Key facts

INN cyproterone
Brand CYPROTERONE SANDOZ

Approval history

Authority Status Date
TGA approved

Pipeline programs

  1. Cyproterone acetate Phase 3 · Takeda · Adenocarcinoma, Prostate
  2. Cyproterone acetate 5 Phase 2 · Teva Pharma · Prostate Cancer
  3. Cyproterone acetate/ethinylestradiol (CPA/EE) Phase 2 · Universal Integrated · Polycystic Ovarian Syndrome
  1. US 11376263

    Cyproterone acetate compositions and uses thereof

    Expires Mon Jun 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 8288342

    Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetate

    Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is cyproterone?

cyproterone (CYPROTERONE SANDOZ) is an FDA-listed pharmaceutical active ingredient. Associated with Amdipharm Mercury (Australia) Pty Limited.

What is the brand name for cyproterone?

CYPROTERONE SANDOZ is a marketed brand name for cyproterone. Check FDA Drugs@FDA for the current US label holder and prescribing information.